Z-1571-2016 Class II Terminated
FDA device recall Z-1571-2016 was initiated by Hardy Diagnostics on Mar 21, 2016 and is designated Class II. Reason for recall: Performance failure; poor hemolytic reaction of non or weakly hemolytic group B streptococcus (GBS) with the target QC organism, Streptococcus agalactiae (ATCC 13813) due to product deterioration. The recall status is terminated (terminated Oct 25, 2016). Affected quantity: 3,530 (353 pk/10).
Recall details
- Product Type
- Devices
- Report Date
- May 4, 2016
- Initiation Date
- Mar 21, 2016
- Termination Date
- Oct 25, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,530 (353 pk/10)
Product description
Reason for recall
Distribution pattern
U.S. Distribution to the following states: AL, SC, FL, CT, VA, WI, MA, MI, WV, OH, IN, IL, NC, and TX.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1571-2016
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Hardy Diagnostics? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.